Revelation Biosciences, Inc.
REVBW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810560
No open-market purchases or sales by Revelation Biosciences, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $9.99K in total; no superinvestor holds it.
Other share classesREVB
13F holders, Q1 2023
Institutional positions in Revelation Biosciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +7 vs. Q4 2022
- Shares held
- 2.03M
- +358.5K (+21.4%) vs. Q4 2022
- Total value
- $33.4K
- +$11.9K (+55.0%) vs. Q4 2022
- New holders
- 9
- 1 more added
- Sold out
- 2
- 1 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting REVBW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $9.99K |
| Q1 2026 | 11 | $6.66K |
| Q4 2025 | 11 | $10.2K |
| Q3 2025 | 11 | $13.0K |
| Q2 2025 | 12 | $13.8K |
| Q1 2025 | 9 | $10.5K |
| Q4 2024 | 11 | $6.76K |
| Q3 2024 | 13 | $18.6K |
| Q2 2024 | 14 | $25.9K |
| Q1 2024 | 12 | $36.1K |
| Q4 2023 | 12 | $20.9K |
| Q3 2023 | 14 | $31.6K |
| Q2 2023 | 12 | $30.0K |
| Q1 2023 | 17 | $33.4K |
| Q4 2022 | 11 | $23.6K |
| Q3 2022 | 12 | $123.0K |
| Q2 2022 | 17 | $208.0K |
| Q1 2022 | 18 | $389.0K |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Revelation Biosciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Linden Advisors LP | 715,752 | $12.8K | 0.00% | 00.0% | Unchanged |
| Yakira Capital Management, Inc. | 246,884 | $4.00K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 187,001 | $3.03K | 0.00% | +187,001 | New |
| Ionic Capital Management LLC | 171,189 | $2.77K | 0.00% | +171,189 | New |
| Walleye Trading LLC | 104,990 | $1.70K | 0.00% | +104,990 | New |
| B. Riley Financial, Inc. | 100,000 | $1.62K | 0.00% | +100,000 | New |
| Cowen and Company, LLC | 98,296 | $1.59K | 0.00% | +98,296 | New |
| Jane Street Group, LLC | 80,746 | $1.31K | 0.00% | −1,814−2.2% | Reduced |
| Ayrton Capital LLC | 75,000 | $1.22K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 74,007 | $1.20K | 0.00% | 00.0% | Unchanged |
| Pine Valley Investments Ltd Liability Co | 43,865 | $786 | 0.00% | +43,865 | New |
| Privium Fund Management B.V. | 44,000 | $713 | 0.00% | 00.0% | Unchanged |
| Equitec Proprietary Markets, LLC | 20,000 | $324 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 17,139 | $278 | 0.00% | +17,139 | New |
| UBS Group AG | 6,089 | $97 | 0.00% | +6,089 | New |
| Flow Traders U.S. LLC | 15,566 | $0 | 0.00% | +407+2.7% | Added |
| Virtu Financial LLC | 29,616 | $0 | 0.00% | +29,616 | New |
| Owl Creek Asset Management, L.P. | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −98,296−100.0% | Sold out |
| Telemetry Investments, L.L.C. | – | – | – | – | Not filed |